Findings of EMANATE, presented during ESC 2017 in Barcelona, trial support the use of apixaban in patient with atrial fibrillation undergoing cardioversion. The results discussed by Michael Ezekowitz (Sidney Kimmel Medical College).
Quando invii il modulo, controlla la tua inbox per confermare l'iscrizione.